Health systems, payers and healthcare vendors have a different problem from a single clinic: large legacy sites, multiple stakeholders, and buying cycles measured in quarters.
At organisational scale, the barrier to organic growth is rarely a lack of content. It is accumulated structure — a site that has absorbed a decade of reorganisations, microsites, acquisitions and campaign pages, none of which were retired.
The result is predictable: thousands of indexed URLs competing with each other, authority spread thin, and the pages that matter most for acquisition buried beneath pages nobody has owned in years. Publishing more into that environment changes very little.
Work at this level starts with consolidation and architecture, not with a content calendar. It also has to survive an organisation — clinical review, brand governance, legal, and an IT function with its own roadmap. Strategy that ignores those realities does not ship.
Large healthcare sites accumulate duplicate service pages, orphaned microsites and abandoned campaign URLs. Every one of them dilutes topical authority and competes with the page you actually want ranking. Consolidation is unglamorous and it is usually the single highest-return intervention available.
Whether the buyer is a hospital procurement committee or a patient choosing a health system, the decision involves several people over an extended period. Search strategy has to cover the full arc — early problem framing through vendor comparison to final validation — not just the transactional query at the end.
Brand, legal, clinical and IT all hold veto power. A strategy requiring forty new pages that each need four approvals will not ship. Sequencing work so that early wins need the fewest sign-offs is how these engagements build the credibility to tackle harder changes later.
Many healthcare organisations run on platforms where template changes require developer time and a release window. Knowing what is achievable inside those constraints — and what genuinely justifies engineering effort — is the difference between a strategy that ships and a document that gets filed.
Auditing legacy sprawl, retiring or merging competing URLs, and rebuilding an architecture that concentrates authority instead of splitting it.
Consistent organisational data across every property, with credentialed authorship and reviewer attribution built into templates.
Coverage across problem framing, solution comparison and final validation — sequenced around the approvals each stage requires.
Entity consistency and extractable content so generative systems describe your organisation and services accurately at scale.
Repeatable templates for service lines and facilities that survive governance and can be maintained by your team.
Qualified enquiries and service-line conversions, instrumented within your privacy and security constraints.
We work with a small number of healthcare and health-technology companies at a time. The pattern recognition from that focus — what YMYL scrutiny actually rewards, how clinical review really behaves — is the product.
AI search visibility is engineered here, not offered as a workshop bolted onto an SEO retainer. Entity data, extractable content and citation strategy are built into the work from the first phase.
No account managers, no junior handoff, no roster of forty clients. You work directly with the operator doing the work, in 90-day cycles with no annual lock-in.
Directness about sequencing. At organisational scale the first phase is usually consolidation and technical repair rather than new content, and any firm promising rankings before it has seen your indexation profile is guessing. You should also expect an explicit view of which stakeholders must approve what.
Yes, with the caveat that we are a small studio. We are a good fit for a defined mandate — a service line, a consolidation programme, an AI visibility initiative — and a poor fit for a full-service marketing retainer across an entire system.
Practices need visibility built. Organisations usually need visibility recovered — untangling structure that already exists. The technical and political work is a much larger share of the engagement, and the content share is smaller.
Often, yes. A common arrangement is that we own technical and architectural strategy while an incumbent handles content production and campaigns. That works well provided the division is explicit from the start.
Entity consistency does most of the work. Large organisations frequently describe themselves differently across their own properties, which makes them harder for generative systems to represent confidently. Fixing that, then building extractable, well-cited content, is the substance of GEO at enterprise scale.
Organic sessions and rankings are diagnostics. The reportable outcomes are qualified enquiries, service-line conversions and AI citation share — instrumented in a way that does not transmit identifiable patient information to third parties.
Most agencies treat a medical practice like any other local business, then discover halfway through that everything they publish needs clinical sign-off. We build for that from the first week.
If nobody is searching for what you built, keyword research returns nothing and paid acquisition gets expensive fast. Organic still works — it just has to start from the problem instead of the product.
When you run multiple clinicians, several locations and a set of distinct programmes, search stops being a content problem and becomes an architecture problem.
A 30-minute conversation about your organic growth, your AI visibility, and whether we are the right partner. No decks, no pitch — just diagnostics.